BSE filing, BSE: 544529. Summary written from the filing by ALFA Finder's alert engine.
Aptus Pharma Ltd: key numbers
- Share price
- ₹462.50
- Market cap
- ₹793.2 Cr
- Revenue (annual)
- ₹46.57 Cr
- Net profit (annual)
- ₹4.62 Cr
- P/E (TTM)
- 171.7×Sector 45.9×
- Promoter holding
- 72.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aptus Pharma Ltd
All →Aptus Pharma Preferential Issue
Aptus Pharma got BSE in-principle approval for a preferential issue of 15,99,270 shares at a minimum Rs. 280 each. The issue is worth about Rs. 44.78 Crore.
- Value
- ₹44.78 Cr
Aptus Pharma Investor Presentation: Key Takeaways
H1 FY27 revenue ₹48.92 Cr, EBITDA ₹7.68 Cr (15.7% margin), PAT ₹5.07 Cr; revenue exceeds full FY26 (₹46.57 Cr). Trading-heavy model with rising receivables and negative operating cash flow.
Aptus Pharma H1 FY27 Results: Net Profit ₹5.1 Cr, Up 200.0% YoY
Aptus Pharma Ltd reported revenue from operations of ₹48.9 Cr (+239.6% YoY) and net profit of ₹5.1 Cr (+200.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹5.1 Cr · +200.0% YoY
Aptus Pharma Other Announcement
Aptus Pharma Limited submitted the Regulation 74(5) compliance certificate for the quarter and half-year ended 30th September 2026, as received from its registrar.
Aptus Pharma Annual General Meeting
Aptus Pharma Ltd issued a corrigendum to its 16th AGM notice regarding inadvertent errors in the explanatory statement for item no. 3.
Aptus Pharma Fund Raise of ₹44.88 Cr
Aptus Pharma Limited's Board has approved raising ₹44.88 Crore through a preferential equity issue. Funds will support manufacturing capacity expansion, working capital, and Pan-India growth initiatives.
- Value
- ₹44.88 Cr
- Execution
- 36 months
Other board meeting outcome announcements
All →Emergent Industrial Solutions Board Meeting Outcome
Emergent Industrial Solutions reconstituted its four board committees, reassigning existing directors across Audit, Nomination, Stakeholders Relationship, and CSR roles. This is routine governance with no financial impact.
Winsol Engineers Board Meeting Outcome
Winsol Engineers' board approved AoA changes to allow voluntary dividend waiver and postal ballot logistics. All decisions are routine governance matters with no material business impact.
Nirlon Board Meeting Outcome
Nirlon Ltd's board approved a modification to its Dividend Distribution Policy on November 2, 2026. This is a routine governance update with no dividend declared or cash impact.
Novus Loyalty Board Meeting Outcome
Novus Loyalty's board approved voluntary quarterly financial reporting from the December 2026 quarter, enhancing transparency beyond the mandatory half-yearly SME disclosure requirement.
Bharat Global Developers Board Meeting Outcome
Board approved shifting registered office within Ahmedabad and postponed Q1 and H1 FY27 financial results to a subsequent meeting. No material business decision was taken.
Pasari Spinning Mills Board Meeting Outcome
Pasari Spinning Mills reconstituted its Audit, NRC and SRC committees after an independent director resigned and Ms. Bhavna Agrawal was appointed. The change takes effect from the 30 October 2026 board meeting.